As Oregon lawmakers stare down a deficit of at least $373 million over the next two years — and brace for the possibility of ...

Booking Holdings stock outperformed expectations for Q3, but faces a valuation challenge. Here's what investors need to keep ...

Cholesteryl ester transfer protein inhibition has previously demonstrated significant efficacy in reducing atherogenic lipids and may benefit high-risk patients who are unable to achieve their LDL ...

Members of South Dakota state government committee were curious about tourism jobs and other data during a presentation by ...

Acadia Realty Trust recently posted strong results, with 8.2% same-store NOI growth and impressive leasing momentum. Learn ...

University of Wisconsin-Milwaukee and University at Buffalo investigators report that diabetes fatalism is associated with ...

New criteria that put greater emphasis on body composition to diagnose obesity show greater prevalence of the disease in the ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ('Indaptus” or the 'Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today ...

Q3-25 Revenue rose 148% YOY to $2.9M DVLT Discusses New Global Business Pipeline Raises FY 2025 Revenue Guidance to a low end of $30M, Raises ...

Safe Pro Group Inc. (Nasdaq: SPAI) ("Safe Pro" or the "Company"), a developer of AI-enabled defense and security solutions, today provided an operational update highlighting progress across its ...

ADVANCED-2 (NCT05951179) is a Phase 2 open-label trial assessing intravesical TARA-002 in NMIBC patients with carcinoma in situ or CIS (± Ta/T1) who are Bacillus Calmette-Guérin (BCG)-Unresponsive ...

Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd.